Search results
Results from the WOW.Com Content Network
On March 20, 2024, Neuralink introduced the person who had received the first Neuralink implant in the clinical trial as 29-year-old Noland Arbaugh through a livestream on X. Arbaugh had become a quadriplegic after experiencing a diving accident dislocated his C4 and C5 spinal vertebrae. Later in the livestream, Noland demonstrated his ability ...
This trial is expected to enroll three patients to evaluate its device in a study expected to take several years to complete, according to details on the U.S. government's clinical trials database.
Elon Musk wants to try Neuralink as soon as it is ready, but the company has delayed human trials several times.
Some of the staff at Elon Musk's Neuralink are making preparations to sell the brain implant company's stock in the wake of its valuation jumping following its first human trial, according to ...
In 2020, scientists out of the University of Melbourne, who formed the company Synchron in 2016, published clinical data related to a discovery for Stentrode, a device implanted via the jugular vein, without the need for open brain surgery. The technology was shown to enable two patients to control a computer using thought alone.
Expanded access or compassionate use is the use of an unapproved drug or medical device under special forms of investigational new drug applications (IND) or IDE application for devices, outside of a clinical trial, by people with serious or life-threatening conditions who do not meet the enrollment criteria for the clinical trial in progress.
The threads have stabilized for Arbaugh, Neuralink said. Reuters had reported Neuralink was aware of this issue from its animal trials. Musk's Neuralink says second trial implant went well, no ...
The United States Food and Drug Administration's Investigational New Drug (IND) program is the means by which a pharmaceutical company obtains permission to start human clinical trials and to ship an experimental drug across state lines (usually to clinical investigators) before a marketing application for the drug has been approved.